Result of GM and Total Voting Rights

Gelion PLC
27 November 2023
 

 

27 November 2023

Gelion plc

("Gelion" or the "Company" or the "Group")

 

Result of GM and Total Voting Rights

 

Gelion (AIM: GELN), the Anglo-Australian battery innovator, announces that at the General Meeting ("GM") held earlier today, all resolutions set out in the Notice of GM were duly passed. Following this, as of 8am on 28 December 2023 the total number of voting rights will be 135,998,459.

 

The voting results for each resolution were as follows:

 


In Favour

Against

Withheld

Votes

Resolution

Votes

%

Votes

%

1 - To authorise the directors to allot shares pursuant to the Placing, Subscription, Retail Offer, and the acquisition of OXLiD Ltd.

42,660,711

99.99

183

Less than 0.01

None

2 - To authorise the directors to disapply the statutory pre-emption rights in relation to the allotment of shares pursuant to the Placing, Subscription and Retail Offer.

42,597,271

99.85

406

Less than 0.01

63,217

 

The results of the GM will also be available from today on the Company's website at www.gelion.com

 

CONTACTS

 

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

via Alma

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

+44 207 220 0500

Corporate Finance

Neil McDonald

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 


Alma Strategic Communications

Justine James

Hannah Campbell

Will Ellis Hancock

+44 20 3405 0205

gelion@almastrategic.com

 

About Gelion

 

Gelion ("gel: ion") is a global -energy storage innovator, supporting the transition to a more sustainable economy by commercialising two globally important next generation technologies: Lithium-Sulfur (LiS) and Zinc-based (Zn) hybrid cells to electrify mobile and stationary applications. Gelion plc (the Group) is listed on the London Stock Exchange's Alternative Investment Market and wholly owns Australia based Gelion Technologies Pty Ltd.  Gelion is designing and delivering innovative battery technology to enable that transition and return value for its customers and investors.

 

Lithium Sulfur

Gelion's effort is directed at the potential for the LiS chemistry to deliver double the gravimetric energy density of standard Lithium-ion chemistries whilst at the same time reducing cost and increasing safety targeting the EV and e-aviation market, helping to make global transport, energy consumption and storage more sustainable.

 

Gelion is developing a product for its high energy density sulfur cathode at its expanded R&D facilities in Sydney, enabling it to integrate with a variety of anodes ranging from graphite to silicon to lithium metal, depending on the targeted application.

 

Gelion recently also expanded in the UK1 by acquiring OXLiD Ltd, significantly increasing Gelion's capability in cathode improvement thereby accelerating path to commercial partners and commercialisation.

 

Zinc

Gelion is adapting its zinc technology to comprise an alternate cathode technology, a zinc hybrid cell to develop complementary next-generation batteries for the lead-acid eco-system. Early testing indicates that this solution has the potential to maintain good energy density levels with enhanced cost and safety aspects. Once fully developed, Gelion intends for our zinc technology to provide a durable and sustainable market extension within the ecosystem that supports lead-acid batteries.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Gelion (GELN)
UK 100

Latest directors dealings